- Latest week
- 17 Jul 2026
- Close
- 66475.000000
- Fair value
- 39676.298396
- Next-week expectancy
- Undecided 49.79%
AZN Chart Pack
AstraZeneca PLC
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, AZN fell 5.74%, moving from 70,525.00 to 66,475.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -17.13 and has softened across the 12-week window. Market Dynamics is -0.26 on the latest week. Next-week expectancy is undecided at 49.79% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 66,475.00
- 12-Week Change
- -5.74%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 49.79%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -17.13
- Market Dynamics
- -0.26
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 66,475.00
- 12-Week Change
- -5.74%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 49.79%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -17.13
- Market Dynamics
- -0.26
Over the latest 12 completed weeks ending 2026-07-17, AZN fell 5.74%, moving from 70,525.00 to 66,475.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -17.13 and has softened across the 12-week window. Market Dynamics is -0.26 on the latest week. Next-week expectancy is undecided at 49.79% based on similar historical setup states.
Industry Peers
Argentina equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | BUE | 17 Jul 2026 | 30120.00 | 32560.00 | 29420.00 | 31940.00 | 6.04% |
| ABBV AbbVie Inc. | BUE | 17 Jul 2026 | 38460.01 | 40940.00 | 37744.84 | 40320.00 | 4.84% |
| GILD Gilead Sciences, Inc. | BUE | 17 Jul 2026 | 50900.00 | 55075.00 | 50550.00 | 53025.00 | 4.17% |
| PFE Pfizer Inc. | BUE | 17 Jul 2026 | 9500.00 | 10060.00 | 9385.00 | 9885.00 | 4.05% |
| BIIB Biogen Inc. | BUE | 17 Jul 2026 | 24000.00 | 26040.00 | 22380.00 | 24890.00 | 3.71% |
| MRK Merck & Co., Inc. | BUE | 17 Jul 2026 | 38800.00 | 41460.00 | 37540.00 | 40160.00 | 3.51% |
| AMGN Amgen Inc. | BUE | 17 Jul 2026 | 18880.00 | 19780.00 | 18410.00 | 19200.00 | 1.69% |
| NVS Novartis AG | BUE | 17 Jul 2026 | 60175.00 | 60875.00 | 58100.00 | 60675.00 | 0.83% |
| LLY Eli Lilly and Company | BUE | 17 Jul 2026 | 33100.00 | 33560.00 | 31480.00 | 33160.00 | 0.18% |
| DJNJ3 Johnson & Johnson | BUE | 17 Jul 2026 | 1640.00 | 1640.00 | 1640.00 | 1640.00 | 0.00% |
| GSK GSK plc | BUE | 17 Jul 2026 | 20550.00 | 20690.00 | 19940.00 | 20470.00 | -0.39% |
| JNJ Johnson & Johnson | BUE | 17 Jul 2026 | 27000.00 | 27160.00 | 25460.00 | 26600.00 | -1.48% |